Works matching AU Sridhar, Vikas S.

Results: 24
    1

    Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 8, p. 4415, doi. 10.1111/dom.16478
    By:
    • Beernink, Jelle M.;
    • Jongs, Niels;
    • Mosterd, Charlotte M.;
    • Scholtes, Rosalie A.;
    • Caldwell‐McGee, Alyssa;
    • Casillas, Daniel;
    • Driscoll, Lynette;
    • Greasley, Peter J.;
    • Karlsson, Cecilia;
    • Hammarstedt, Ann;
    • Sridhar, Vikas S.;
    • Muskiet, Marcel H. A.;
    • Laverman, Gozewijn D.;
    • Cherney, David Z. I.;
    • Bjornstad, Petter;
    • van Raalte, Daniel H.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    2
    3
    4
    5

    Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter‐2 inhibitors for the treatment of diabetes mellitus in liver transplant recipients.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 10, p. 4261, doi. 10.1111/dom.15769
    By:
    • Zheng, Katina;
    • Azhie, Amirhossein;
    • You, Xiaoting;
    • Naghibzadeh, Maryam;
    • Tan, Eunice;
    • Naimimohasses, Sara;
    • Sridhar, Vikas S.;
    • Gupta, Sarang;
    • Chen, Shiyi;
    • Dash, Satya;
    • Tsien, Cynthia;
    • Selzner, Nazia;
    • Lilly, Leslie;
    • Jaeckel, Elmar;
    • Woo, Minna;
    • Singh, Sunita;
    • Cherney, David;
    • Bhat, Mamatha
    Publication type:
    Article
    6
    7
    8
    9
    10
    11

    Cardiorenal Protection in Diabetic Kidney Disease.

    Published in:
    Endocrinology & Metabolism, 2021, v. 36, n. 2, p. 256, doi. 10.3803/EnM.2021.987
    By:
    • Lee, Jason F.;
    • Berzan, Ecaterina;
    • Sridhar, Vikas S.;
    • Odutayo, Ayodele;
    • Cherney, David Z. I.
    Publication type:
    Article
    12

    Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy?

    Published in:
    2025
    By:
    • Kugathasan, Luxcia;
    • Dutta, Pritha;
    • Nardone, Massimo;
    • Sridhar, Vikas S.;
    • Campbell, David J.T.;
    • Layton, Anita T.;
    • Perkins, Bruce A.;
    • Barbour, Sean;
    • Lam, Tony K.T.;
    • Levin, Adeera;
    • Lovblom, Leif Erik;
    • Mucsi, Istvan;
    • Rabasa-Lhoret, Remi;
    • Rac, Valeria E.;
    • Senior, Peter;
    • Sigal, Ronald J.;
    • Vukobradovic, Aleksandra;
    • Persson, Frederik;
    • Stougaard, Elisabeth B.;
    • Doria, Alessandro
    Publication type:
    Letter
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.

    Published in:
    Diabetes & Vascular Disease Research, 2022, v. 19, n. 5, p. 1, doi. 10.1177/14791641221130043
    By:
    • Stougaard, Elisabeth B;
    • Kristensen, Peter L;
    • Kielgast, Urd;
    • Andersen, Henrik U;
    • Hamid, Yasmin;
    • Gæde, Peter H;
    • Søndergaard, Esben;
    • Dørflinger, Gry H;
    • Fjeldborg, Karen K;
    • Hansen, Klavs W;
    • Thomsen, Henrik H;
    • Al-Imar, Thuraya M.J.;
    • Røder, Michael;
    • Sridhar, Vikas S;
    • Cherney, David;
    • Rossing, Peter;
    • Persson, Frederik
    Publication type:
    Article
    22

    Mechanistic evaluation of ertugliflozin in patients with type 2 diabetes and heart failure.

    Published in:
    Physiological Reports, 2025, v. 13, n. 7, p. 1, doi. 10.14814/phy2.70275
    By:
    • Lytvyn, Yuliya;
    • Scholtes, Rosalie A.;
    • Boorsma, Eva M.;
    • Sridhar, Vikas S.;
    • Kugathasan, Luxcia;
    • Liu, Hongyan;
    • Lovblom, Leif E.;
    • Handoko, Louis;
    • Mosterd, Charlotte M.;
    • Floras, John S.;
    • Burns, Kevin;
    • Osuntokun, Tosin;
    • Voors, Adriaan;
    • van Raalte, Daniel H.;
    • Heerspink, Hiddo J. L.;
    • Cherney, David Z. I.
    Publication type:
    Article
    23
    24